Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.4K Hold
410
﹤0.01% 664
2026
Q1
$86K Hold
410
﹤0.01% 587
2025
Q4
$117K Hold
410
﹤0.01% 528
2025
Q3
$127K Hold
410
﹤0.01% 517
2025
Q2
$129K Sell
410
-50
-11% -$14.4K ﹤0.01% 495
2025
Q1
$121K Hold
460
﹤0.01% 503
2024
Q4
$120K Sell
460
-3
-0.6% -$756 ﹤0.01% 507
2024
Q3
$108K Sell
463
-50
-10% -$10.3K ﹤0.01% 512
2024
Q2
$104K Buy
513
+338
+193% +$60.9K ﹤0.01% 505
2024
Q1
$30K Buy
+175
New +$32.6K ﹤0.01% 683
2023
Q4
Sell
-300
Closed -$47.8K 1025
2023
Q3
$47.8K Buy
+300
New +$67.2K ﹤0.01% 582
2022
Q1
Sell
-100
Closed -$27K 1125
2021
Q4
$27K Sell
100
-8
-7% -$2.32K ﹤0.01% 712
2021
Q3
$31K Buy
108
+50
+86% +$14.3K ﹤0.01% 673
2021
Q2
$16K Buy
58
+50
+625% +$13.6K ﹤0.01% 779
2021
Q1
$2K Hold
8
﹤0.01% 1057
2020
Q4
$2K Buy
+8
New +$1.99K ﹤0.01% 1026

Other funds holding PODD

HM Payson & Co's PODD Position: Q2 2026 in Review

HM Payson & Co held its Insulet (PODD) position steady in Q2 2026 at 410 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

HM Payson & Co first reported a position in PODD in Q4 2020 and has held it in 16 quarters since. The position peaked at $129K in Q2 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • HM Payson & Co held 410 shares of Insulet worth $62.4K as of Q2 2026.
  • HM Payson & Co left its Insulet share count unchanged in Q2 2026.
  • Insulet made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #664 holding.
  • HM Payson & Co first reported a position in Insulet in Q4 2020 and has held it in 16 quarters since.
  • HM Payson & Co's Insulet position peaked at $129K in Q2 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.